CW
PBE icon

CreativeOne Wealth’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

CreativeOne Wealth’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$968K Buy
12,219
+835
+7% +$67.5K 0.02% 592
2025
Q4 		$935K Sell
11,384
-532
-4% -$41.2K 0.02% 576
2025
Q3 		$833K Sell
11,916
-3,417
-22% -$231K 0.02% 614
2025
Q2 		$983K Sell
15,333
-2,566
-14% -$159K 0.03% 540
2025
Q1 		$1.14M Sell
17,899
-4,466
-20% -$300K 0.03% 440
2024
Q4 		$1.49M Sell
22,365
-5,127
-19% -$353K 0.05% 355
2024
Q3 		$1.92M Sell
27,492
-7,360
-21% -$510K 0.07% 276
2024
Q2 		$2.26M Sell
34,852
-5,499
-14% -$348K 0.11% 183
2024
Q1 		$2.61M Buy
40,351
+12,564
+45% +$818K 0.1% 179
2023
Q4 		$1.83M Buy
27,787
+2,306
+9% +$134K 0.12% 172
2023
Q3 		$1.45M Sell
25,481
-3,048
-11% -$186K 0.1% 184
2023
Q2 		$1.75M Buy
28,529
+7,599
+36% +$474K 0.08% 236
2023
Q1 		$1.31M Buy
20,930
+1,987
+10% +$128K 0.06% 261
2022
Q4 		$1.2M Sell
18,943
-6,241
-25% -$396K 0.07% 257
2022
Q3 		$1.48M Buy
+25,184
New +$1.55M 0.09% 199

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

CreativeOne Wealth's PBE Position: Q1 2026 in Review

CreativeOne Wealth increased its Invesco Biotechnology & Genome ETF (PBE) stake by 7.3% in Q1 2026, buying an estimated $67.5K and bringing the position to 12,219 shares worth $968K. The position accounts for 0.02% of the portfolio, ranked #592.

CreativeOne Wealth first reported a position in PBE in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.61M in Q1 2024. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • CreativeOne Wealth held 12,219 shares of Invesco Biotechnology & Genome ETF worth $968K as of Q1 2026.
  • CreativeOne Wealth bought 835 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $67.5K.
  • Invesco Biotechnology & Genome ETF made up 0.02% of CreativeOne Wealth's portfolio in Q1 2026, its #592 holding.
  • CreativeOne Wealth first reported a position in Invesco Biotechnology & Genome ETF in Q3 2022 and has held it in 15 quarters since.
  • CreativeOne Wealth's Invesco Biotechnology & Genome ETF position peaked at $2.61M in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.